Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
Oct 1, 2019Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene TherapyFinancial Support for LabCentral Incubators Builds on Astellas' $1 Billion+ Investment in Boston's Life Science Community
Sep 30, 2019- Finalists will present their ideas during a live pitch event
Sep 28, 2019Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer- Study Met Outcomes for Safety and 71 Percent of Patients with Locally Advanced or Metastatic Urothelial (Bladder) Cancer Had a Confirmed Response -
- Sep 24, 2019- Astellas named Working Mother "100 Best Company" for fifth consecutive year -